Patents by Inventor John E. Eriksson

John E. Eriksson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions of Anisomelic acid and the use thereof
    Patent number: 9623002
    Abstract: A pharmaceutical composition for anti-viral cancer treatment in mammals, comprising a therapeutically effective amount of Anisomelic acid or salts thereof. The pharmaceutical composition may comprise Anisomelic acid or salt thereof in an oil-in-water emulsion, for example in an isotropic mixture of at least one oil and at least one surfactant or, alternatively, in a hydrophilic solvent and a co-solvents or surfactant or a combination thereof. A method of treating or preventing of cancer in a mammal, wherein the p53 pathway is deregulated by viral oncoproteins, is also provided.
    Type: Grant
    Filed: August 17, 2015
    Date of Patent: April 18, 2017
    Inventors: John E. Eriksson, Preethy Paul, Emilia Peuhu, M. A. Akbarsha
  • Pharmaceutical compositions of anisomelic acid and the use thereof
    Patent number: 9345687
    Abstract: A pharmaceutical composition for anti-viral cancer treatment in mammals, comprising a therapeutically effective amount of Anisomelic acid or salts thereof. The pharmaceutical composition may comprise Anisomelic acid or salt thereof in an oil-in-water emulsion, for example in an isotropic mixture of at least one oil and at least one surfactant or, alternatively, in a hydrophilic solvent and a co-solvents or surfactant or a combination thereof. A method of treating or preventing of cancer in a mammal, wherein the p53 pathway is deregulated by viral oncoproteins, is also provided.
    Type: Grant
    Filed: August 28, 2013
    Date of Patent: May 24, 2016
    Inventors: John E. Eriksson, Preethy Paul, Emilia Peuhu, M. A. Akbarsha
  • Pharmaceutical compositions of Anisomelic acid and the use thereof
    Publication number: 20160136126
    Abstract: A pharmaceutical composition for anti-viral cancer treatment in mammals, comprising a therapeutically effective amount of Anisomelic acid or salts thereof. The pharmaceutical composition may comprise Anisomelic acid or salt thereof in an oil-in-water emulsion, for example in an isotropic mixture of at least one oil and at least one surfactant or, alternatively, in a hydrophilic solvent and a co-solvents or surfactant or a combination thereof. A method of treating or preventing of cancer in a mammal, wherein the p53 pathway is deregulated by viral oncoproteins, is also provided.
    Type: Application
    Filed: August 17, 2015
    Publication date: May 19, 2016
    Inventors: John E. Eriksson, Preethy Paul, Emilia Peuhu, M.A. Akbarsha